Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVidendum Plc Regulatory News (VID)

Share Price Information for Videndum Plc (VID)

Share Price is delayed by 15 minutes
Get Live Data
338.00    -30.00 (-8.15%)
Bid:
340.00
Ask:
350.00
Spread: 10.00 (2.941%)
Market Cap: £136.19m
VID Live PriceLast checked at - London Stock Exchange

Intraday Videndum Plc Share Chart

Update announcement

16 Oct 2025 07:00

RNS Number : 5632D
Videndum PLC
16 October 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

16 October 2025

 

Videndum plc

Update announcement

 

Videndum plc (the "Company" or the "Group") provides an update on trading for the three months to 30 September 2025 ("Q3" or "the period") and ongoing negotiations with its RCF lenders. 

 

Current trading

Following seasonally low activity in July and August, recent order intake has been strong, particularly in the US. As at 30 September 2025, the order book was up c.40% year-on-year, a significant improvement on the prior period, benefiting from September order intake 6% higher than the same period in 2024; the highest in over a year. Q3 revenue improved to 8% lower year-on-year (excluding the impact of the 2024 Paris Olympics), after a first half decline of 25%.

 

Combined with the benefits of previously announced £19 million cost saving programmes coming through as expected, the Group's financial performance in 2025 is strengthening with Q3 EBITDA 50% higher than that achieved in H1. Given the limited inventory in the markets, any uptick in end market demand will feed through into revenue with little delay. Allied to previously announced management actions, any improvement in revenue will drop through to operating profit at a significant rate. Accordingly, the Board's expectations for FY26 remain unchanged.

 

As previously announced on 3 September 2025, the Company sold its consumer orientated JOBY brand to VIJIM. Gross cash proceeds will be c.£5 million, of which 80% has been received, with the balance in escrow to follow within the next six months.

 

Net debt as at 30 September 2025 was £139 million, including £27 million of finance leases. 

 

Ongoing negotiations with the Group's RCF lenders

The Company continues to make constructive progress with its lending banks on a deleveraging plan and has met its September EBITDA covenant.

 

As outlined previously in its 30 April 2025 and 6 August 2025 RNS announcements, any plan to deleverage the business will require alternative new sources of liquidity including, but not limited to, any combination of proceeds from disposals and the raising of new debt or equity.

 

While constructive discussions regarding the deleveraging plan remain ongoing and further work is required, lenders have requested a trailing last twelve-month October EBITDA covenant of £10 million in addition to the requirement to agree the deleveraging plan in October. The Company has agreed to this stretching EBITDA target with an expectation that sufficient progress will be made on the deleveraging plan such that, should trading fall short or the deleveraging plan not be agreed, lenders will waive or defer both covenants.

 

A further announcement will be made as and when appropriate.

 

Enquiries

FTI Consulting

Richard Mountain / Ben Fletcher

Telephone: 020 3272 1340

 

Videndum

Stephen Harris

Group Executive Chairman

Telephone: 020 8332 4602

 

A snapshot of Videndum plc

Videndum is a leading global provider of premium branded hardware products and software solutions to the content creation market.

Videndum's customers include broadcasters, film studios, production and rental companies, photographers, independent content creators ("ICCs"), professional musicians and enterprises. Our product portfolio includes camera supports, video transmission systems and monitors, live streaming solutions, robotic camera systems, prompters, LED lighting, mobile power, carrying solutions, backgrounds, audio capture, and noise reduction equipment.

We employ around 1,300 people across the world in 9 different countries. Videndum plc is listed on the London Stock Exchange, ticker: VID.

More information can be found at: https://videndum.com/

LEI number: 2138007H5DQ4X8YOCF14

 

This announcement contains inside information for the purposes of the market abuse regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended. The person responsible for arranging the release of this announcement on behalf of Videndum is Jon Bolton.

 

This announcement may contain forward-looking statements, which relate, inter alia, to the Company's proposed strategy, plans and objectives. Forward-looking statements are sometimes identified by the use of terminology such as (but not limited to) "believes", "expects", "may", "will", "could", "shall", "risk", "intends", "estimates", "aims", "plans", "predicts", "continues", "assumes", "positions" or "anticipates" or the negatives thereof, other variations thereon or comparable terminology. By its very nature, such forward-looking information requires the Company to make assumptions that may or may not materialise. Although the Directors consider that these assumptions are reasonable, such forward-looking statements may involve known and unknown risks, uncertainties, assumptions and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Group to be materially different from such forward-looking statements. Past performance is not a reliable indicator of future results and, in particular, past performance of the Group cannot be relied upon as a guide to future performance. Forward-looking statements speak only as of the date they are made. Accordingly, you should not rely on any forward-looking statements and the Company, Lazard and Investec expressly disclaim any obligation to disseminate any updates or revisions to such forward-looking statements. No statement in this announcement is intended as a profit forecast or a profit estimate and no statement in this announcement should be interpreted to mean that earnings per share for the current or future financial periods would necessarily match or exceed historical published earnings per share. As a result, you are cautioned not to place any undue reliance on such forward-looking statements. Neither the Company nor anyone else is under any obligation to update or keep current the information contained in this announcement.

 

This announcement is not a prospectus and not an offer of shares or any other securities for sale and investors should not subscribe for or purchase any shares or securities referred to in this announcement except on the basis of the information in any prospectus, including the risk factors set out therein, that may be published by the Company in due course in relation to a potential offer for sale of new ordinary shares in the capital of the Company and admission of those ordinary shares to trading on London Stock Exchange plc's main market for listed securities and to listing in the equity shares (commercial companies) category of the official list of the FCA.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVRBRVKURAAA
Date   Source Headline
8th Dec 202311:30 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20231:04 pmRNSResults of Capital Raising and General Meeting
5th Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSTotal Voting Rights
21st Nov 202312:56 pmRNSPublication of Prospectus
21st Nov 20237:00 amRNSCompletion of Bookbuild
20th Nov 20235:27 pmRNSProposed Capital Raising
20th Nov 20237:00 amRNSBlock listing Interim Review
9th Nov 20237:00 amRNSAppointment of Director & Chairman Designate
8th Nov 20239:56 amRNSGraham Oldroyd change of role
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSDirectorate Change
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
9th Oct 202310:00 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:45 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:35 pmRNSTotal Voting Rights
26th Sep 20237:00 amRNSDirectorate Change
26th Sep 20237:00 amRNSVidendum plc - 2023 Interim Results
25th Sep 20234:37 pmRNSRevised publication date of 2023 Interim Results
14th Sep 202312:00 pmRNSBlocklisting Application for Sharesave and LTIP
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20234:47 pmRNSHolding(s) in Company
24th Aug 202310:57 amRNSHolding(s) in Company
9th Aug 20234:33 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSRevision of Half Year Results Date
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 202311:30 amRNSNew directorship held in another UK plc
30th Jun 20232:00 pmRNSTotal Voting Rights
19th Jun 20235:11 pmRNSHolding(s) in Company
1st Jun 20238:47 amRNSTotal Voting Rights
19th May 20238:00 amRNSBlock listing Interim Review
11th May 20231:09 pmRNSResult of 2023 Annual General Meeting
9th May 202310:45 amRNSDirector/PDMR Shareholding
2nd May 20233:14 pmRNSUpdate Announcement
2nd May 20239:49 amRNSTotal Voting Rights
19th Apr 20235:05 pmRNSHolding(s) in Company
13th Apr 20234:15 pmRNSNew directorship held in another public company
4th Apr 202312:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSAnnual Report & Accounts and Notice of 2023 AGM
10th Mar 20239:24 amRNSHolding(s) in Company
3rd Mar 202311:15 amRNSDirector/PDMR Shareholding
1st Mar 202311:03 amRNSTotal Voting Rights
28th Feb 20237:00 amRNS2022 Full Year Results
1st Feb 20239:00 amRNSTotal Voting Rights
3rd Jan 202310:30 amRNSTotal Voting Rights
14th Dec 20227:00 amRNSBoard changes
5th Dec 202210:16 amRNSHolding(s) in Company
1st Dec 20221:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.